Method
We reviewed our prostatectomy series from 1991 to 1998, and identi®ed all patients with a PSA 20, and/or a prostate biopsy result showing total Gleason sum of 8 or greater. They constitute the study group herein. The patients were subdivided into those who underwent RRP alone (group 1), those who underwent neoadjuvant hormonal therapy and RRP (group 2), and those who underwent RRP with both neoadjuvant and adjuvant hormonal therapy (group 3).
Results
Though a signi®cant number of patients had recurrence, many patients remained disease-free at time of most recent follow-up (mean follow-up of 43 months; range 11 ± 84 months). We present the characteristics and recurrence rate in each of these groups and for the entire group.
Conclusion
Radical prostatectomy should not necessarily be denied to patients with PSA 20 and/or a prostate biopsy with a total Gleason sum of 8 or greater.
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